{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:31:51Z","timestamp":1769848311536,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","advancesradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.adro.2024.101555","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:14:30Z","timestamp":1719360870000},"page":"101555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of the COVID-19 Pandemic on Hypofractionated Radiation Therapy Use for Breast Cancer in Japan: A Nationwide Study"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-4744","authenticated-orcid":false,"given":"Misuzu","family":"Fujita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokuzo","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Onouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2024.101555_bib0001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2020.04.001","article-title":"Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement","volume":"146","author":"Guckenberger","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0002","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2020.04.016","article-title":"Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement","volume":"107","author":"Thomson","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101555_bib0003","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14737140.2020.1785290","article-title":"Radiotherapy in the era of COVID-19","volume":"20","author":"Lancia","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.adro.2024.101555_bib0004","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.adro.2020.03.011","article-title":"Adapting radiation therapy treatments for patients with breast cancer during the covid-19 pandemic: hypo-fractionation and accelerated partial breast irradiation to address World Health Organization recommendations","volume":"5","author":"Al-Rashdan","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0005","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood.2020006028","article-title":"ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic","volume":"135","author":"Yahalom","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101555_bib0006","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(20)30743-9","article-title":"The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study","volume":"22","author":"Spencer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0007","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/bju.15699","article-title":"Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer","volume":"130","author":"Nossiter","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2024.101555_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2022.11.018","article-title":"The impact of COVID-19 on radiotherapy services in Scotland, UK: a population-based study","volume":"35","author":"Grocutt","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2024.101555_bib0009","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3332\/ecancer.2020.1052","article-title":"COVID-19: hypofractionation in the Radiation Oncology Department during the 'state of alarm': first 100 patients in a private hospital in Spain","volume":"14","author":"Larrea","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.adro.2024.101555_bib0010","doi-asserted-by":"crossref","first-page":"e13770","DOI":"10.1002\/acm2.13770","article-title":"Radiation therapy practice changes in the COVID-19 pandemic era: a pilot study in California","volume":"23","author":"Liu","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.adro.2024.101555_bib0011","article-title":"Trends in radiation oncology treatment fractionation at a single academic center, 2010 to 2020","volume":"7","author":"Cher","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0012","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.3390\/curroncol28040269","article-title":"Evaluating the impact of the COVID-19 pandemic on new cancer diagnoses and oncology care in Manitoba","volume":"28","author":"Decker","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0013","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/curroncol28010018","article-title":"Catching the wave: quantifying the impact of COVID on radiotherapy delivery","volume":"28","author":"Roberge","year":"2020","journal-title":"Curr Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0014","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijrobp.2022.04.054","article-title":"Evaluating the short-term environmental and clinical effects of a Radiation Oncology Department's response to the COVID-19 pandemic","volume":"115","author":"Cheung","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101555_bib0015","article-title":"Impact of the first wave of COVID-19 pandemic on radiotherapy practice at Tata Memorial Centre, Mumbai: a longitudinal cohort study","volume":"8","author":"Tibdewal","year":"2022","journal-title":"JCO global oncology"},{"key":"10.1016\/j.adro.2024.101555_bib0016","article-title":"Impact of the COVID-19 pandemic on Radiation Oncology Departments in Brazil","volume":"7","author":"Oliveira","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0017","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2021.01.003","article-title":"Hypofractionated radiotherapy in the real-world setting: an international ESTRO-GIRO survey","volume":"157","author":"Rodin","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0018","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1007\/s00432-022-04557-2","article-title":"Changes in the number of cancer diagnosis practices due to the COVID-19 pandemic: interrupted time-series analysis using the National Database of Japan","volume":"149","author":"Fujita","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0019","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1038\/s41598-023-32317-w","article-title":"Impact of coronavirus disease 2019 pandemic on breast cancer surgery using the National Database of Japan","volume":"13","author":"Fujita","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.adro.2024.101555_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102391","article-title":"Changes in colorectal cancer treatment during the COVID-19 pandemic in Japan: Interrupted time-series analysis using the National Database of Japan","volume":"85","author":"Fujita","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.adro.2024.101555_bib0021","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-021-01235-8","article-title":"Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions","volume":"21","author":"Schaffer","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.adro.2024.101555_bib0022","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2024.101555_bib0023","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0024","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0026","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"Trialists' Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2024.101555_bib0027","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0028","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2024.101555_bib0029","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0030","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00317","article-title":"Three-year outcomes with hypofractionated versus conventionally fractionated whole-breast irradiation: results of a randomized, noninferiority clinical trial","volume":"36","author":"Shaitelman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jjco\/hyy160","article-title":"A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906","volume":"49","author":"Nozaki","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101555_bib0032","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/jjco\/hyac174","article-title":"Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study)","volume":"53","author":"Mitsuyoshi","year":"2023","journal-title":"Jpn J Clin Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424001180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424001180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T18:26:56Z","timestamp":1726424816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109424001180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2452109424001180"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2024.101555","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the COVID-19 Pandemic on Hypofractionated Radiation Therapy Use for Breast Cancer in Japan: A Nationwide Study","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2024.101555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101555"}}